STOCK TITAN

Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results on February 7, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Vanda Pharmaceuticals Inc. (VNDA) will release its Q4 and full year 2023 results on February 7, 2024. The company will host a conference call to discuss the financial results and corporate activities. Investors can participate via phone or webcast, with a replay available until February 14, 2024.
Positive
  • None.
Negative
  • None.

Conference Call and Webcast to Follow

WASHINGTON, Jan. 31, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the fourth quarter and full year 2023 on Wednesday, February 7, 2024, after the market closes.  

Vanda will host a conference call at 4:30 PM ET on Wednesday, February 7, 2024, during which management will discuss the fourth quarter and full year 2023 financial results and other corporate activities. To participate in the conference call, please dial 1-800-715-9871 (domestic) or 1-646-307-1963 (international) and use passcode 8053170.

The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.

A replay of the call will be available on Wednesday, February 7, 2024, beginning at 8:30 PM ET and will be accessible until Wednesday, February 14, 2024, at 11:59 PM ET. The replay call-in number is 1-800-770-2030 for domestic callers and 1-609-800-9909 for international callers. The passcode number is 8053170.

About Vanda Pharmaceuticals Inc.

Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.

Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer 
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-fourth-quarter-and-full-year-2023-financial-results-on-february-7-2024-302049731.html

SOURCE Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals will release its Q4 and full year 2023 results on February 7, 2024.

Investors can participate in the conference call by dialing 1-800-715-9871 (domestic) or 1-646-307-1963 (international) and using passcode 8053170.

The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com.

The replay of the call will be available until February 14, 2024, and can be accessed by dialing 1-800-770-2030 for domestic callers and 1-609-800-9909 for international callers, using passcode 8053170.
Vanda Pharmaceuticals Inc

NASDAQ:VNDA

VNDA Rankings

VNDA Latest News

VNDA Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Health Technology, Biotechnology, Manufacturing, Pharmaceutical Preparation Manufacturing
US
Washington

About VNDA

vanda is a specialty pharmaceutical company focused on the development and commercialization of novel therapies to address high unmet medical needs and improve the lives of patients.